Molecular and clinical findings in patients with LHX4 and OTX2 mutations

Clinical Pediatric Endocrinology

Volumn 22, Issue 2, 2013, Pages 15-23

  Tajima, Toshihiro ^a   Ishizu, Katsura ^a   Nakamura, Akie ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Combined pituitary hormone deficiency; LHX4; Mutation; OTX2

Indexed keywords

HYPOPHYSIS HORMONE;

CLINICAL FEATURE; COMBINED PITUITARY HORMONE DEFICIENCY; ENVIRONMENTAL FACTOR; GENE; GENE MUTATION; GENETIC DISORDER; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HORMONE DEFICIENCY; HUMAN; HYPOPHYSIS; LHX4 GENE; ORGANOGENESIS; OTX2 GENE; PLASTICITY; REVIEW;

EID: 84876851187     PISSN: 09185739     EISSN: 13477358     Source Type: Journal    
DOI: 10.1297/cpe.22.15     Document Type: Review

References (36)

1. Cushman LJ, Showalter AD, Rhodes SJ. Genetic defects in the development and function of the anterior pituitary gland. Ann Med 2002;34:179-91. [Medline]
2. Kelberman D, Dattani MT. The role of transcription factors implicated in anterior pituitary development in the aetiology of congenital hypopituitarism. Ann Med 2006;38:560-77. [Medline] [CrossRef]
3. Cohen LE. Genetic disorders of the pituitary. Curr Opin Endocrinol Diabetes Obes 2012;19:33-9 Review. [Medline]
4. Pfäffle R, Klammt J. Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. Best Pract Res Clin Endocrinol Metab 2011;25:43-60. [Medline] [CrossRef]
5. Prince KL, Walvoord EC, Rhodes SJ. The role of homeodomain transcription factors in heritable pituitary disease. Nat Rev Endocrinol 2011;7:727-37. [Medline] [CrossRef]
6. Yamashita T, Moriyama K, Sheng HZ, Westphal H. Lhx4, a LIM homeobox gene. Genomics 1997;44:144-6. [Medline] [CrossRef]
7. Howard PW, Maurer RA. Identification of a conserved protein that interacts with specific LIM homeodomain transcription factors. J Biol Chem 2000;275:13336-42. [Medline] [CrossRef]
8. Sheng HZ, Moriyama K, Yamashita T, Li H, Potter SS, Mahon KA, et al. Multistep control of pituitary organogenesis. Science. 1997;278:1809-12. [Medline] [CrossRef]
9. Raetzman LT, Ward R, Camper SA. Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 2002;129:4229-39. [Medline]
10. Machinis K, Pantel J, Netchine I, Léger J, Camand OJ, Sobrier ML, et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001;69:961-8. [Medline] [CrossRef]
11. Machinis K, Amselem S. Functional relationship between LHX4 and POU1F1 in light of the LHX4 mutation identified in patients with pituitary defects. J Clin Endocrinol Metab 2005;90:5456-62. [Medline] [CrossRef]
12. Pfaeffle RW, Hunter CS, Savage JJ, Duran-Prado M, Mullen RD, Neeb ZP, et al. Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies. J Clin Endocrinol Metab 2008;93:1062-71. [Medline] [CrossRef]
13. Castinetti F, Saveanu A, Reynaud R, Quentien MH, Buffin A, Brauner R, et al. A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism. J Clin Endocrinol Metab 2008;93:2790-9. [Medline] [CrossRef]
14. Dateki S, Fukami M, Uematsu A, Kaji M, Iso M, Ono M, et al. Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion. J Clin Endocrinol Metab 2010;95:4043-7. [Medline] [CrossRef]
15. Filges I, Bischof-Renner A, Röthlisberger B, Potthoff C, Glanzmann R, Günthard J, et al. Panhypopituitarism presenting as lifethreatening heart failure caused by an inherited microdeletion in 1q25 including LHX4. Pediatrics 2012;129:e529-34. [Medline] [CrossRef]
16. Takagi M, Ishii T, Inokuchi M, Amano N, Narumi S, Asakura Y, et al. Gradual loss of ACTH due to a novel mutation in LHX4: Comprehensive mutation screening in Japanese patients with congenital hypopituitarism. PLoS One. 2012;7:e46008. [Medline] [CrossRef]
17. Tajima T, Hattori T, Nakajima T, Okuhara K, Tsubaki J, Fujieda K. A novel missense mutation (P366T) of the LHX4 gene causes severe combined pituitary hormone deficiency with pituitary hypoplasia, ectopic posterior lobe and a poorly developed sella turcica. Endocr J 2007;54:637-41. [Medline] [CrossRef]
18. Tajima T, Yorifuji T, Ishizu K, Fujieda K. A novel mutation (V101A) of the LHX4 gene in a Japanese patient with combined pituitary hormone deficiency. Exp Clin Endocrinol Diabetes 2010;118:405-9. [Medline] [CrossRef]
19. Kastury K, Druck T, Huebner K, Barletta C, Acampora D, Simeone A, et al. Chromosome locations of human EMX and OTX genes. Genomics 1994;22:41-5. [Medline] [CrossRef]
20. Chatelain G, Fossat N, Brun G, Lamonerie T. Molecular dissection reveals decreased activity and not dominant negative effect in human OTX2 mutants. J Mol Med 2006;84:604-15. [Medline] [CrossRef]
21. Acampora D, Mazan S, Lallemand Y, Avantaggiato V, Maury M, Simeone A, et al. Forebrain and midbrain regions are deleted in Otx2-/-mutants due to a defective anterior neuroectoderm specification during gastrulation. Development 1995;121:3279-90. [Medline]
22. Ang SL, Jin O, Rhinn M, Daigle N, Stevenson L, Rossant J. A targeted mouse Otx2 mutation leads to severe defects in gastrulation and formation of axial mesoderm and to deletion of rostral brain. Development 1996;122:243-52. [Medline]
23. Kurokawa D, Kiyonari H, Nakayama R, Kimura-Yoshida C, Matsuo I, Aizawa S, et al. Regulation of Otx2 expression and its functions in mouse forebrain and midbrain. Development 2004;131:3319-31. [Medline] [CrossRef]
24. Hide T, Hatakeyama J, Kimura-Yoshida C, Tian E, Takeda N, Ushio Y, et al. Genetic modifiers of otocephalic phenotypes in Otx2 heterozygous mutant mice. Development 2002;129:4347-57. [Medline]
25. Ragge NK, Brown AG, Poloschek CM, Lorenz B, Henderson RA, Clarke MP, et al. Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet 2005;76:1008-22. [Medline] [CrossRef]
26. Elliott J, Maltby EL, Reynolds B. A case of deletion 14(q22.1→q22.3) associated with anophthalmia and pituitary abnormalities. J Med Genet 1993;30:251-2. [Medline] [CrossRef]
27. Nolen LD, Amor D, Haywood A, St Heaps L, Willcock C, Mihelec M, et al. Deletion at 14q22-23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomalies. Am J Med Genet A 2006;140:1711-8. [Medline]
28. Diaczok D, Romero C, Zunich J, Marshall I, Radovick S. A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency. J Clin Endocrinol Metab 2008;93:4351-9. [Medline] [CrossRef]
29. Spieler D, Baumer N, Stebler J, Koprunner M, Reichman-Fried M, Teichmann U, et al. Involvement of Pax6 and Otx2 in the forebrainspecific regulation of the vertebrate homeobox gene ANF/Hesx1. Dev Biol 2004;269:567-9. [Medline] [CrossRef]
30. Dateki S, Fukami M, Sato N, Muroya K, Adachi M, Ogata T. OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters. J Clin Endocrinol Metab 2008;93:3697-702. [Medline] [CrossRef]
31. Dateki S, Kosaka K, Hasegawa K, Tanaka H, Azuma N, Yokoya S, et al. Heterozygous orthodenticle homeobox 2 mutations are associated with variable pituitary phenotype. J Clin Endocrinol Metab 2010;95:756-64. [Medline] [CrossRef]
32. Tajima T, Ohtake A, Hoshino M, Amemiya S, Sasaki N, Ishizu K, et al. OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. J Clin Endocrinol Metab 2009;94:314-9. [Medline] [CrossRef]
33. Ashkenazi-Hoffnung L, Lebenthal Y, Wyatt AW, Ragge NK, Dateki S, Fukami M, et al. A novel loss-of-function mutation in OTX2 in a patient with anophthalmia and isolated growth hormone deficiency. Hum Genet 2010;127:721-9. [Medline] [CrossRef]
34. Henderson RH, Williamson KA, Kennedy JS, Webster AR, Holder GE, Robson AG, et al. A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction. Mol Vis 2009;15:2442-7. [Medline]
35. Schilter KF, Schneider A, Bardakjian T, Soucy JF, Tyler RC, Reis LM, et al. OTX2 microphthalmia syndrome: four novel mutations and delineation of a phenotype. Clin Genet 2011;79:158-68. [Medline] [CrossRef]
36. Gorbenko Del Blanco D, Romero CJ, Diaczok D, de Graaff LC, Radovick S, Hokken-Koelega AC. A novel OTX2 mutation in a patient with combined pituitary hormone deficiency, pituitary malformation, and an underdeveloped left optic nerve. Eur J Endocrinol 2012;167:441-52. [Medline] [CrossRef]